US Patent 12077594 IL2RG binding molecules and methods of use
Patent 12077594 was granted and assigned to Synthekine on September, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+17 properties)
Article (+258 characters)
US Patent 12077594 IL2RG binding molecules and methods of use
Article
Patent abstract
The present disclosure relates to biologically active molecules comprising a single domain antibody (sdAb) that specifically binds to the extracellular domain of human IL2Rg, compositions comprising such antibodies, and methods of use thereof.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Deepti Rokkam0
Patrick J. Lupardus0
Robert Kastelein0
Sandro Vivona0
Date of Patent
September 3, 2024
0Patent Application Number
180065250
Date Filed
August 5, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12077594 IL2RG binding molecules and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.